Long-term effectiveness of verapamil in stable and unstable angina pectoris: One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials
- 30 November 1982
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 50 (5) , 1185-1190
- https://doi.org/10.1016/0002-9149(82)90441-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administrationThe American Journal of Cardiology, 1981
- Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectorisThe American Journal of Medicine, 1981
- Intravenous Verapamil for Termination of Re-Entrant Supraventricular TachycardiasAnnals of Internal Medicine, 1980
- Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.Circulation, 1980
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.Circulation, 1979
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation, 1979
- Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogramAmerican Heart Journal, 1975
- Clinical Evaluation of Verapamil in Angina PectorisBMJ, 1968
- Verapamil in angina: a double-blind trial.BMJ, 1968
- DOUBLE BLIND EVALUATION OF ORALLY ADMINISTERED IPROVERATRIL IN PATIENTS WITH ANGINA PECTORISThe Lancet Healthy Longevity, 1966